Immunome Inc reports results for the quarter ended in March - Earnings Summary

Immunome

10/05/2023 14:31

* Immunome Inc  IMNM.OQ  reported a quarterly adjusted loss
of 35
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for earnings of
59 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Immunome Inc's reported EPS for the quarter was a loss
of 35
cents​.
    * The mean earnings estimate of analysts had risen by
about 177%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Immunome Inc shares had risen by 25.3% this quarter and
gained 182.8% so far this year.
    * The company reported a quarterly loss of $4.27 million.
    * Wall Street's median 12-month price target for Immunome
Inc is
$8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.59           -0.35          Missed
 Dec. 31 2022      -0.67          -0.64          Beat
 Sep. 30 2022      -0.76          -0.75          Beat
 Jun. 30 2022      -0.75          -0.74          Beat